Introduction
============

Coronary artery aneurysm is a rare disorder characterized by an abnormal dilatation (diameter \>50% of the normal adjacent segments) of a localized or diffuse portion of the coronary artery \[[@B1],[@B2]\]. The detected incidence on angiography varies from 0.3% to 4.9% in large studies \[[@B1],[@B2]\]. Atherosclerosis is the most common etiology estimated at 50% of cases diagnosed in adults; independent of the etiology, the aneurysmal segment produces turbulent blood flow with an increased incidence of myocardial ischemic manifestations (acute coronary syndromes, thromboembolism, rupture or vasospasm) \[[@B3]-[@B5]\]. The indication for treatment and the best modalities still need to be defined \[[@B6]\]. In recent years different studies have reported the treatment of coronary aneurysm with the polytetrafluoroethylene (PTFE) covered stents as a valuable alternative to surgery in selected cases (diameter six to 10mm) \[[@B7],[@B8]\]. However, the use of this device is limited by its dimension, by the low flexibility (that makes implantation very difficult in tortuous vessels), by the lack of access of side branches and by the inherent risk of restenosis. The MGuard™stent (InspireMD Ltd, Tel Aviv, Israel) is a novel coronary device composed of a multicellular stainless steel stent with an integrated polyethylene terephthalate (PET) protective sleeve mesh (15 μm single PET knit fiber with 150 μm × 150 μm apertures) (Figure [1a](#F1){ref-type="fig"}). The sleeve acts as a snowshoe, averaging the expansion impact while preventing embolic dislodgment. This stent has a high flexibility and a low profile that can challenge very complex anatomies; the process of endothelization of this device transforms the mesh sleeve into a membrane that has the potential to seal coronary aneurysms \[[@B9],[@B10]\].

![**Coronary angiography and CT scan before and after MGuard stent implantaion**. (A) The unexpanded (top) and the expanded stent covered with a sleeve mesh (bottom). Reproduced with permission from InspireMD. (B) Angiography of the right coronary artery with the presence of a large saccular aneurysm involving the distal part of the artery to the crux cordis. (C) Partial opacification of the aneurysmal sac through the holes of the mesh just after stent implantation. (D) Coronary angiography at one month follow-up showing the exclusion of the aneurysm. (E) Coronary CT scan at one month: multiplanar reformation of the right coronary artery near the crux cordis; on the right ventricle side of the distal part of the stent, is clearly demonstrated the water density remnant of the treated aneurysm (arrows): low density fat is surrounding the proximal stent. (F) Coronary CT scan at one month: The magnified view of the stent allows for a better identification of the treated aneurysm (arrows).](1752-1947-4-238-1){#F1}

Case presentation
=================

A 68-year-old Italian-Caucasian man who had a previous angioplasty to an obtuse marginal branch presented to our institution for angina and a positive myocardial perfusion imaging test (reversible perfusion defects on inferior wall). An angiography showed a patent stent on obtuse marginal artery and a large coronary aneurysm of the right coronary artery (6.7 mm in diameter and 15.2 mm in length) (Figure [1b](#F1){ref-type="fig"}; additional file [1](#S1){ref-type="supplementary-material"})\[[@B1],[@B2]\]. A 3.5 to 24 mm long MGuard™stent was implanted, using a pressure of 16 bar (additional file [2](#S2){ref-type="supplementary-material"}). After stent deployment, the injection of dye showed partial opacification of the aneurysmal sac through the holes of the net, with some stagnation of blood (Figure [1c](#F1){ref-type="fig"}; additional file [3](#S3){ref-type="supplementary-material"}). His hospital stay was uneventful and our patient was discharged the day after the procedure with dual anti-platelet therapy. At one month our patient was totally asymptomatic. The coronary computed tomography (CT) scan showed a good stent apposition (Figure [1e,f](#F1){ref-type="fig"}) with complete exclusion of the aneurysm that was also confirmed by angiography (Figure [1d](#F1){ref-type="fig"}; additional file [4](#S4){ref-type="supplementary-material"}).

Conclusions
===========

Coronary artery aneurysms may be complicated by thrombosis and rupture. The optimal treatment options of coronary aneurysms are still largely debated. They include anticoagulation, covered stents, reconstruction, resection and exclusion with bypass \[[@B11]\]. The PTFE-covered stents have been used to treat coronary artery aneurysms, but the restenosis rate and long-term effectiveness of covered stents are unknown. The newly developed balloon-expandable MGuard™stent system with its combination of an ultra-thin polymer mesh sleeve attached to the external of a bare metal stent surface has been designed to provide embolic protection during percutaneous coronary intervention restenosis by bare metal stents, peripheral embolism following stent implantation in vein grafts, and conditions in which there is a discontinuity of the coronary lumen (rupture or perforation, aneurysm, and fistula). This device demonstrated excellent performance in a highly complex lesion subset such as cover coronary artery perforations or arteriovenous fistulas with high success and acceptable rates of acute complications. Based on its technical features, we decided to use the MGuard™stent to seal a coronary artery aneurysm. This experience suggests a new potential indication for the use of MGuard™coronary stent as an attractive alternative treatment with less risk of in-stent restenosis. In human coronary arteries the complete exclusion of the aneurysmal sac (that is mediated by the process of endothelization of the ultra-thin PET mesh sleeve) is not immediate and seems to require at least four weeks. The high flexibility and the good deliverability make the MGuard™device an attractive alternative to the currently available covered stent for an effective treatment of coronary aneurysm.
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###### Additional file 1

**Coronary angiography showing a large coronary artery aneurysm**. Right anterior oblique view of the right coronary artery with the presence of a large aneurysm involving the distal part of the artery till the crux cordis.
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###### Additional file 2

**MGuard stent implantation**. Stent deployment at a pressure of 16 bar.
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###### Additional file 3

**Coronary angiography after stent implantation**. Opacification of the aneurysmal sac through the holes of the net, with some stagnation of blood.
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###### Additional file 4

**Coronary angiography at one month follow up**. Follow-up angiography at one month showing the complete exclusion of the aneurysmal sac.

###### 

Click here for file
